| Prediction of acute myeloid leukaemia risk in healthy individuals S Abelson, G Collord, SWK Ng, O Weissbrod, N Mendelson Cohen, ... Nature 559 (7714), 400-404, 2018 | 771 | 2018 |
| The high Nrf2 expression in human acute myeloid leukemia is driven by NF-κB and underlies its chemo-resistance SA Rushworth, L Zaitseva, MY Murray, NM Shah, KM Bowles, ... Blood, The Journal of the American Society of Hematology 120 (26), 5188-5198, 2012 | 314 | 2012 |
| Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment MS Shafat, T Oellerich, S Mohr, SD Robinson, DR Edwards, CR Marlein, ... Blood, The Journal of the American Society of Hematology 129 (10), 1320-1332, 2017 | 292 | 2017 |
| NADPH oxidase-2 derived superoxide drives mitochondrial transfer from bone marrow stromal cells to leukemic blasts CR Marlein, L Zaitseva, RE Piddock, SD Robinson, DR Edwards, ... Blood, The Journal of the American Society of Hematology 130 (14), 1649-1660, 2017 | 290 | 2017 |
| Diagnosis of post‐transplant lymphoproliferative disorder in solid organ transplant recipients–BCSH and BTS Guidelines A Parker, K Bowles, JA Bradley, V Emery, C Featherstone, G Gupte, ... British journal of haematology 149 (5), 675-692, 2010 | 236 | 2010 |
| Management of post‐transplant lymphoproliferative disorder in adult solid organ transplant recipients–BCSH and BTS Guidelines A Parker, K Bowles, JA Bradley, V Emery, C Featherstone, G Gupte, ... British journal of haematology 149 (5), 693-705, 2010 | 218 | 2010 |
| Splenomegaly: investigation, diagnosis and management AL Pozo, EM Godfrey, KM Bowles Blood reviews 23 (3), 105-111, 2009 | 187 | 2009 |
| CD38-driven mitochondrial trafficking promotes bioenergetic plasticity in multiple myeloma CR Marlein, RE Piddock, JJ Mistry, L Zaitseva, C Hellmich, RH Horton, ... Cancer Research 79 (9), 2285-2297, 2019 | 175 | 2019 |
| Platelet size has diagnostic predictive value in patients with thrombocytopenia KM Bowles, LJ Cooke, EM Richards, TP Baglin Clinical & Laboratory Haematology 27 (6), 370-373, 2005 | 173 | 2005 |
| Impact of hemoglobin levels and anemia on mortality in acute stroke: analysis of UK regional registry data, systematic review, and meta‐analysis RS Barlas, K Honney, YK Loke, SJ McCall, JH Bettencourt‐Silva, ... Journal of the American Heart Association 5 (8), e003019, 2016 | 154 | 2016 |
| Impact of stroke‐associated pneumonia on mortality, length of hospitalization, and functional outcome WH Teh, CJ Smith, RS Barlas, AD Wood, JH Bettencourt‐Silva, AB Clark, ... Acta Neurologica Scandinavica 138 (4), 293-300, 2018 | 147 | 2018 |
| The bone marrow microenvironment–Home of the leukemic blasts MS Shafat, B Gnaneswaran, KM Bowles, SA Rushworth Blood reviews 31 (5), 277-286, 2017 | 146 | 2017 |
| Identification of Bruton’s tyrosine kinase as a therapeutic target in acute myeloid leukemia SA Rushworth, MY Murray, L Zaitseva, KM Bowles, DJ MacEwan Blood, The Journal of the American Society of Hematology 123 (8), 1229-1238, 2014 | 140 | 2014 |
| Ibrutinib in relapsed chronic lymphocytic leukemia. JC Byrd, S O'Brien, DF James The New England journal of medicine 369 (13), 1278-1279, 2013 | 130 | 2013 |
| BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-κB SA Rushworth, KM Bowles, LN Barrera, MY Murray, L Zaitseva, ... Cellular signalling 25 (1), 106-112, 2013 | 128 | 2013 |
| How much residual plasma may cause TRALI? N Win, CE Chapman, KM Bowles, A Green, S Bradley, D Edmondson, ... Transfusion Medicine 18 (5), 276-280, 2008 | 127 | 2008 |
| Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial J Trotman, SF Barrington, D Belada, M Meignan, R MacEwan, C Owen, ... The Lancet Oncology 19 (11), 1530-1542, 2018 | 125 | 2018 |
| HOXB4 overexpression promotes hematopoietic development by human embryonic stem cells KM Bowles, L Vallier, JR Smith, MRJ Alexander, RA Pedersen Stem Cells 24 (5), 1359-1369, 2006 | 111 | 2006 |
| High basal nuclear levels of Nrf2 in acute myeloid leukemia reduces sensitivity to proteasome inhibitors SA Rushworth, KM Bowles, DJ MacEwan Cancer research 71 (5), 1999-2009, 2011 | 104 | 2011 |
| ROS-mediated PI3K activation drives mitochondrial transfer from stromal cells to hematopoietic stem cells in response to infection JJ Mistry, CR Marlein, JA Moore, C Hellmich, EE Wojtowicz, JGW Smith, ... Proceedings of the National Academy of Sciences 116 (49), 24610-24619, 2019 | 93 | 2019 |
